BlackRock Institutional Trust’s Ligand Pharmaceuticals LGND Stock Holding History

BlackRock Institutional Trust’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$50.6M	Buy	798,238 +38,208	+5%	+$2.41M	0.01%	1345
2016 Q3	$48.4M	Sell	760,030 -40,367	-5%	-$2.96M	0.01%	1322
2016 Q2	$59.6M	Buy	800,397 +41,306	+5%	+$3.07M	0.01%	1131
2016 Q1	$50.7M	Buy	759,091 +165	+0%	+$10K	0.01%	1209
2015 Q4	$51.3M	Sell	758,926 -2,004	-0.3%	-$124K	0.01%	1226
2015 Q3	$40.7M	Sell	760,930 -68,369	-8%	-$4.15M	0.01%	1352
2015 Q2	$52.2M	Sell	829,299 -86,165	-9%	-$4.7M	0.01%	1271
2015 Q1	$44M	Sell	915,464 -15,337	-2%	-$588K	0.01%	1396
2014 Q4	$30.9M	Buy	930,801 +54,205	+6%	+$1.76M	﹤0.01%	1623
2014 Q3	$25.7M	Sell	876,596 -74,126	-8%	-$2.46M	﹤0.01%	1725
2014 Q2	$36.9M	Buy	950,722 +34,951	+4%	+$1.42M	0.01%	1536
2014 Q1	$38.4M	Buy	915,771 +37,151	+4%	+$1.55M	0.01%	1489
2013 Q4	$28.8M	Sell	878,620 -38,847	-4%	-$1.27M	0.01%	1666
2013 Q3	$24.8M	Sell	917,467 -159,547	-15%	-$4.49M	﹤0.01%	1701
2013 Q2	$25.1M	Buy	+1,077,014	New	+$19.4M	0.01%	1630

Other funds holding LGND

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

DMK

David M. Knott $275M AUM 59.23% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

CCMLC

Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock Institutional Trust's LGND Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Ligand Pharmaceuticals (LGND) stake by 5% in Q4 2016, buying an estimated $2.41M and bringing the position to 798,238 shares worth $50.6M. The position accounts for 0.01% of the portfolio, ranked #1345.

BlackRock Institutional Trust first reported a position in LGND in Q2 2013 and has held it in 15 quarters since. The position peaked at $59.6M in Q2 2016. 270 funds tracked by Wall St. Rank hold LGND as of Q4 2016.

BlackRock Institutional Trust held 798,238 shares of Ligand Pharmaceuticals worth $50.6M as of Q4 2016.
BlackRock Institutional Trust bought 38,208 Ligand Pharmaceuticals shares in Q4 2016, an estimated $2.41M.
Ligand Pharmaceuticals made up 0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #1345 holding.
BlackRock Institutional Trust first reported a position in Ligand Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
BlackRock Institutional Trust's Ligand Pharmaceuticals position peaked at $59.6M in Q2 2016.
270 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.